Residency · Residency · Vascular Surgery

Tibial and Pedal Artery Interventions for Limb Salvage

Overview

Infrapopliteal artery disease, affecting the tibial and pedal arteries, is a defining feature of critical limb-threatening ischemia (CLTI). This condition is most commonly observed in patients with diabetes and those suffering from end-stage renal disease. The advent of endovascular tibial interventions has revolutionized limb salvage, especially for patients who are poor candidates for surgery. The primary objective of these interventions is to restore inline blood flow to the foot, which is essential for wound healing and alleviating rest pain.

Anatomy

Tibial Arteries

The anterior tibial artery (ATA) travels anteriorly through the interosseous membrane and continues as the dorsalis pedis artery at the ankle. The tibioperoneal trunk is a short common vessel that bifurcates into the posterior tibial artery (PTA) and the peroneal artery. The PTA courses behind the medial malleolus and gives rise to the plantar arteries, which supply the sole of the foot. The peroneal artery runs along the fibula, providing collateral circulation but rarely reaches the foot directly. The pedal arteries include the dorsalis pedis (a continuation of the ATA), the lateral and medial plantar arteries (branches of the PTA), and the pedal arch, which connects these vessels.

Angiosome Concept

The foot is divided into distinct vascular territories known as angiosomes, each supplied by a specific source artery. The ATA and dorsalis pedis artery supply the dorsum of the foot. The PTA and its calcaneal branch supply the medial ankle and plantar heel, while the medial and lateral plantar branches of the PTA supply the medial midfoot and forefoot, and the lateral forefoot, respectively. The peroneal artery’s calcaneal branch supplies the lateral ankle and lateral heel. The angiosome-directed revascularization approach aims to improve wound healing by restoring direct blood flow to the ischemic territory corresponding to the wound location.

<image>Anatomical diagram of the foot angiosomes showing the vascular territories supplied by the anterior tibial/dorsalis pedis, posterior tibial (medial plantar, lateral plantar, calcaneal branches), and peroneal arteries, with wound locations mapped to their corresponding angiosomes</image>

Indications for Tibial Intervention

Tibial interventions are primarily indicated for patients with CLTI who exhibit tissue loss, classified as Rutherford stages 5-6 or WIfI stages 3-4. They are also warranted in cases of rest pain that is refractory to medical management and are essential for wound healing when proximal revascularization alone is insufficient. These interventions are generally not indicated for claudication, as tibial disease rarely causes claudication in isolation.

Diagnostic Evaluation

The toe-brachial index (TBI) is more reliable than the ankle-brachial index (ABI) in patients with diabetes or calcified vessels; a TBI less than 0.7 is abnormal, and values below 0.25 indicate critical ischemia. Transcutaneous oxygen pressure (TcPO2) measurements below 30 mmHg suggest inadequate healing potential, while skin perfusion pressure (SPP) values under 40 mmHg are associated with poor wound healing. Duplex ultrasound is used to assess tibial artery patency and blood flow velocity. Computed tomography angiography (CTA) is preferred for preoperative planning, especially in calcified vessels, whereas magnetic resonance angiography (MRA) may overestimate stenosis. Definitive assessment is achieved through catheter angiography, which is typically performed at the time of intervention.

Endovascular Techniques

Access Strategies

Antegrade ipsilateral femoral access is the preferred approach for most tibial interventions due to its direct route. Contralateral femoral crossover access is an alternative but requires a longer working length. Retrograde pedal access is invaluable when antegrade crossing fails; this involves puncturing the dorsalis pedis or posterior tibial artery under ultrasound guidance using a small sheath (4F or micropuncture). This technique facilitates a "rendezvous" approach where the retrograde wire meets the antegrade wire. Retrograde tibial access involves direct puncture of tibial vessels at the ankle and is another option for challenging cases.

Crossing Techniques

For crossing tibial lesions, low-profile 0.014" or 0.018" guidewire systems are preferred, often hydrophilic wires such as Command or Astato, supported by catheters like CXI or Rubicon. Subintimal crossing may be necessary for long occlusions but is more challenging in small-caliber vessels. The pedal loop technique involves accessing one pedal vessel, crossing through the pedal arch, and entering the target tibial vessel retrogradely, allowing for complex revascularization.

Balloon Angioplasty

Balloon angioplasty remains the cornerstone of tibial interventions. Low-profile balloons ranging from 2.0 to 3.5 mm in diameter and varying lengths are used, with prolonged inflations lasting 2 to 3 minutes to optimize acute results. Stenting is reserved for focal, flow-limiting dissections and is considered provisional. Although primary patency rates at one year are modest (50-60%), limb salvage rates are significantly higher (75-85%). This highlights the key concept that permanent vessel patency is not necessary; the artery only needs to remain open long enough to allow wound healing.

Drug-Coated Balloons (DCB)

The use of drug-coated balloons such as the IN.PACT BTK has yielded mixed results in the tibial territory. Evidence supporting their efficacy is less compelling than in the femoropopliteal segment. Ongoing studies are evaluating sirolimus-coated balloons, which may offer advantages over paclitaxel-coated devices below the knee. Trials like SAVAL and SIRONA are investigating newer DCB platforms.

Stenting in Tibial Arteries

Stenting in tibial arteries is generally avoided due to the small vessel size and high restenosis rates. Bare metal stents are reserved for cases involving flow-limiting dissection or elastic recoil. Drug-eluting stents, typically coronary platforms such as the Xience DES, have shown improved patency in small trials and are sometimes used off-label for short lesions. Absorbable scaffolds offer theoretical benefits by providing temporary support before dissolving, but data on their use in peripheral arteries remain limited.

Atherectomy

Rotational atherectomy is employed for heavily calcified tibial vessels, with orbital atherectomy (CSI) gaining popularity. Atherectomy is often used as vessel preparation before drug-coated balloon angioplasty. However, there is a risk of distal embolization, so embolic protection devices should be used when possible.

<image>Step-by-step fluoroscopic sequence of a retrograde pedal access tibial intervention showing dorsalis pedis artery puncture, retrograde wire crossing of a posterior tibial artery occlusion through the pedal arch, balloon angioplasty, and final angiogram with restored inline pedal flow</image>

Angiosome-Directed vs. Best-Available-Vessel Revascularization

Arguments for Angiosome-Directed

Angiosome-directed revascularization involves directly targeting the artery supplying the ischemic wound territory. Some retrospective studies have demonstrated improved wound healing rates with this approach. Conceptually, it maximizes perfusion to the affected tissue.

Arguments for Best-Available-Vessel

Targeting the technically easiest vessel to treat may yield higher procedural success rates. The extensive collateral network of the pedal arch allows for indirect revascularization, and limited randomized data have not consistently shown superiority of the angiosome-directed approach. In clinical practice, revascularization focuses on the best target that provides inline flow to the foot.

Current Consensus

When technically feasible, the angiosome vessel should be targeted. If this is not possible, restoring any inline flow to the foot takes priority. An open pedal arch enhances the effectiveness of indirect revascularization.

Pedal Loop and Plantar Artery Interventions

Pedal loop reconstruction restores continuity of the pedal arch between the dorsalis pedis and plantar arterial systems. This technique allows perfusion of multiple angiosomes through a single revascularized tibial vessel. Although technically demanding, it is increasingly performed at specialized centers.

Outcomes

Technical success rates for tibial angioplasty range from 85% to 95%. Limb salvage rates at one year are between 75% and 85%, exceeding primary patency rates because vessels may reocclude after wound healing is achieved. Primary patency at one year varies widely depending on lesion complexity but generally falls between 50% and 60%. Wound healing occurs in 50% to 70% of patients within six months following successful revascularization. Mortality remains high in this population, with 20% to 25% of CLTI patients dying within one year, reflecting the severe systemic disease burden.

Complications

Complications include vessel dissection and perforation, which are usually small and self-limiting. Distal embolization is a risk, although the use of embolic protection devices remains debated. Access site complications such as hematoma and pseudoaneurysm can occur. Compartment syndrome is rare after tibial intervention. Contrast-induced nephropathy is a concern, particularly in patients with end-stage renal disease, and CO2 angiography may be considered to mitigate this risk.

Clinical Pearls

Tibial interventions focus on limb salvage rather than maintaining long-term vessel patency; the artery only needs to remain open long enough to facilitate wound healing. It is essential to ensure adequate inflow through the iliac and superficial femoral arteries before addressing tibial disease. Mastery of retrograde pedal access is critical, as it can salvage cases where antegrade crossing fails. The toe-brachial index and transcutaneous oxygen pressure measurements are more reliable than the ankle-brachial index for assessing perfusion in diabetic patients. When confronted with multivessel tibial disease, priority should be given to the vessel that provides the most direct path to the wound, following the angiosome concept if technically feasible. Post-procedural antiplatelet therapy is vital, with dual antiplatelet therapy recommended for at least one to three months. Coordination with wound care and podiatry teams is crucial because revascularization alone does not ensure limb salvage without proper wound management.

<image>Clinical photograph of a diabetic foot with a heel wound before and after successful posterior tibial artery angioplasty, demonstrating wound healing progression at 2, 6, and 12 weeks post-intervention with restoration of direct angiosome flow</image>

References

• Adam DJ, et al. Bypass vs. angioplasty in severe ischaemia of the leg (BASIL). Lancet. 2005;366(9501):1925-1934.
• Kabra A, et al. Tibial and pedal artery interventions for critical limb ischemia. Interv Cardiol Clin. 2017;6(2):251-269.
• Iida O, et al. Importance of angiosome concept in endovascular therapy for infrapopliteal lesions. Catheter Cardiovasc Interv. 2010;75(2):227-235.
• Mustapha JA, et al. Retrograde pedal access for revascularization of infrainguinal peripheral arterial disease. J Vasc Surg. 2020;71(5):1718-1727.
• Conte MS, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S-125S.

Read this lecture as Markdown